SB 143

South Dakota Senate bill in Session 71.

Status: in_committee. Latest action: February 4, 2026.

require that the Department of Health annually report on public health effects of cannabis use.

Bill ID SD-71-SB-143
Session 71
Status in_committee
Committee Senate Health and Human Services
Senate in_committee 2026-02-04
Drug / Cannabis Policy
Summary

An Act to require that the Department of Health annually report on public health effects of cannabis use.

Sponsor
Carley, John
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-27 Introduced Bill introduced
2026-02-04 Status in_committee
2026-02-04 Latest Action Schedule for hearing
More Bills From This Sponsor
SB 175
require that an individual provide proof of citizenship when registering to vote and to declare an emergency.
enacted • Senate
HB 1313
require education in prenatal human growth and development.
enacted • House of Representatives
HB 1066
revise a provision related to theft by a contractor, subcontractor, or supplier.
enacted • House of Representatives
HB 1077
consider a cultivated-protein food product to be adulterated food.
vetoed • House of Representatives
SB 90
expand the information required to be sent to the prescription drug monitoring program for each registry identification card holder.
enacted • Senate
SB 88
clarify the procedure for a potential condemnor to examine real property absent the property owner's permission.
enacted • Senate
More Bills In This Topic
SB 39
revise provisions relating to industrial hemp.
enacted • Senate
SB 42
enhance the penalties for ingestion, possession with intent to deliver, and delivery of a controlled substance in a state correctional facility.
enacted • Senate
HB 1099
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
enacted • House of Representatives
HB 1160
repeal the medical marijuana oversight committee.
in_committee • House of Representatives
HB 1169
classify medetomidine as a Schedule III controlled substance and establish permissible uses.
enacted • House of Representatives
HB 1065
revise the medical purpose affirmative defense in cannabis prosecution.
passed_lower • House of Representatives
Related Topics
Healthcare
9 shared bills
Same Topic Bills From Other States
SB 220
"Putting Georgia's Patients First Act""; enact"
Georgia • 1033 • enacted
HB 108
Division of Correction - Volunteer Services Program
Maryland • 2026 • enacted
SB 433
State agencies (existing): health and human services; educational materials regarding health dangers for youth using high-potency THC and cannabis products; require the department to provide
Michigan • 2025-2026 • in_committee
HB 328
Regulate Hemp-Derived Consumables.
North Carolina • 2025 • unknown
H 3924
A BILL TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY ADDING CHAPTER 56 TO TITLE 46 SO AS TO REGULATE THE SALE OF HEMP-DERIVED CONSUMABLES, AMONG OTHER THINGS.
South Carolina • 126 • passed_upper
HB 133
Income Tax and Sales and Use Tax - Rate Reductions and Alterations
Maryland • 2026 • introduced